```html

Splenic Infarction – Complete Medical Guide

Overview

Splenic infarction (also called splenic ischemia or splenic necrosis) occurs when the blood supply to a portion of the spleen is interrupted, causing tissue death (infarction). The spleen, located in the left upper abdomen, filters blood, recycles red blood cells, and helps fight infection. When its blood vessels become blocked—most often by a clot (thrombus) or embolus—the affected area cannot receive oxygen, leading to pain and, sometimes, serious complications.

Who it affects: Splenic infarction is relatively uncommon, accounting for less than 5% of all abdominal infarctions. It is seen most often in adults aged 30–70, but can occur at any age when underlying conditions are present.

Prevalence: Population‑based studies estimate an incidence of roughly 1–3 cases per 100,000 persons per year in the United States. However, the true number is likely higher because many small, asymptomatic infarcts go undiagnosed.<sup>1</sup>

Symptoms

Symptoms can range from mild discomfort to acute, severe pain. The most common presentations include:

• Left upper‑quadrant abdominal pain – Often described as a sharp or stabbing sensation that may radiate to the left shoulder (Kehr’s sign) or back.
• Left flank pain – May be felt under the ribs or along the side.
• Fever and chills – Usually low‑grade; can indicate infection or inflammation.
• Nausea or vomiting – Frequently accompanies abdominal pain.
• Loss of appetite – Due to abdominal discomfort.
• Palpitations or shortness of breath – May occur if the infarct is part of a larger thrombo‑embolic event (e.g., pulmonary embolism).
• General fatigue or malaise – Result of systemic inflammation.
• Splenomegaly (enlarged spleen) – Occasionally palpable on physical exam.
• Hematemesis or melena – Rare, but can indicate splenic rupture or associated gastrointestinal bleeding.

Because symptoms overlap with many other abdominal conditions (e.g., pancreatitis, peptic ulcer disease, kidney stones), imaging is usually required for a definitive diagnosis.

Causes and Risk Factors

Splenic infarction is essentially a vascular event. The most common mechanisms are:

1. Embolic phenomena

• Cardio‑embolic sources – Atrial fibrillation, recent myocardial infarction, prosthetic heart valves, or infective endocarditis can release clots that travel to the splenic artery.
• Fat emboli – After long‑bone fractures or orthopedic surgery.
• Air or tumor emboli – Rare, associated with invasive procedures or metastatic cancer.

2. Thrombotic disorders

• Hypercoagulable states – Antiphospholipid syndrome, factor V Leiden, protein C/S deficiency, prothrombin gene mutation.
• Myeloproliferative neoplasms – Polycythemia vera, essential thrombocythemia, primary myelofibrosis.
• Sickle cell disease – Vaso‑occlusion can involve the splenic microvasculature.
• Sepsis‑induced disseminated intravascular coagulation (DIC).

3. Vascular disease

• Atherosclerosis of the splenic artery or celiac trunk.
• Vasculitis – e.g., systemic lupus erythematosus, polyarteritis nodosa.

4. Trauma

• Blunt or penetrating abdominal injury can cause splenic vessel disruption leading to infarction, sometimes preceded by hematoma.

5. Iatrogenic causes

• Complications of splenic artery embolization performed for other conditions (e.g., uncontrolled bleeding).
• Radiation or chemotherapy for abdominal malignancies.

Risk factors

• Older age (≥50 years)
• History of atrial fibrillation or other cardiac arrhythmias
• Known hypercoagulable disorder
• Recent surgery or prolonged immobilization
• Chronic inflammatory diseases (e.g., SLE)
• Smoking and uncontrolled hypertension (promote atherosclerosis)
• History of splenic injury or prior splenic procedures

Diagnosis

Because clinical presentation is non‑specific, imaging is the cornerstone of diagnosis.

1. Laboratory studies

• Complete blood count (CBC) – May show leukocytosis, anemia, or thrombocytopenia.
• Coagulation panel – PT/INR, aPTT, D‑dimer (elevated in thrombotic states).
• Lactate dehydrogenase (LDH) – Often increased due to tissue necrosis.
• Blood cultures – If infection/endocarditis is suspected.

2. Imaging

• Contrast‑enhanced computed tomography (CT) of the abdomen – Gold standard. Shows wedge‑shaped, hypodense (low‑attenuation) zones in the spleen that do not enhance with contrast.
• Magnetic resonance imaging (MRI) – Useful when iodinated contrast is contraindicated; diffusion‑weighted imaging can highlight infarcted tissue.
• Color Doppler ultrasound – Can demonstrate absent flow in affected vessels but is less sensitive than CT.
• Angiography – Reserved for cases where endovascular therapy is planned.

3. Additional work‑up to identify underlying cause

• Electrocardiogram and transthoracic or transesophageal echocardiogram (to look for cardiac thrombus or vegetations).
• Hypercoagulable panel (factor V Leiden, antiphospholipid antibodies, protein C/S).
• Bone marrow biopsy or peripheral smear if a myeloproliferative disorder is suspected.

Treatment Options

Treatment is individualized based on the size of the infarct, underlying cause, and the patient’s overall health.

1. Conservative management (most common)

• Pain control – Acetaminophen or short courses of NSAIDs (if no contraindication). Opioids may be needed for severe pain.
• Hydration – Intravenous fluids help maintain perfusion and prevent secondary ischemia.
• Antibiotics – Indicated if there is concern for secondary infection or splenic abscess (e.g., ceftriaxone plus metronidazole).
• Observation – Serial imaging in 4–6 weeks to ensure resolution.

2. Anticoagulation

• First‑line for embolic or thrombotic causes. Low‑molecular‑weight heparin (LMWH) bridges to oral anticoagulants (warfarin with INR 2–3, or direct oral anticoagulants – DOACs such as apixaban, rivaroxaban).
• Duration depends on etiology: 3–6 months for a provoked event, indefinite for unprovoked or persistent hypercoagulable states.

3. Endovascular or surgical interventions

• Selective splenic artery embolization – Used when ongoing bleeding or large infarct threatens splenic viability.
• Splenectomy – Reserved for complications (abscess, rupture, massive infarction, or persistent pain). Laparoscopic approach is preferred when possible.
• Vaccination post‑splenectomy – Immunizations against encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae type b, Neisseria meningitidis) are essential.

4. Managing the underlying disease

• Rate‑control or rhythm‑control strategies for atrial fibrillation.
• Targeted therapy for myeloproliferative disorders (hydroxyurea, interferon‑α, JAK inhibitors).
• Immunosuppression for vasculitis (corticosteroids, cyclophosphamide).

Living with Splenic Infarction

After the acute episode, most patients return to normal life, but some lifestyle adjustments help prevent recurrence and manage residual symptoms.

Daily Management Tips

• Medication adherence – Take anticoagulants exactly as prescribed; set daily alarms if needed.
• Hydration – Aim for at least 8 cups of water daily; dehydration can increase clot risk.
• Activity – Light‑to‑moderate exercise (walking, swimming) improves circulation. Avoid prolonged immobility; stand or walk every 1–2 hours during long trips.
• Diet – Emphasize heart‑healthy foods: plenty of fruits, vegetables, whole grains, lean protein, and omega‑3 fatty acids. Limit excess saturated fat and processed sugars.
• Vaccinations – If the spleen is partially or totally removed, keep immunizations up‑to‑date (pneumococcal, meningococcal, Hib, annual flu).
• Monitor for symptoms – Keep a symptom diary; report new abdominal pain, fever, or unexplained bruising promptly.
• Regular follow‑up – Schedule imaging and blood work per your clinician’s plan (often 3‑month intervals initially).

Prevention

Because many cases are tied to underlying systemic conditions, primary prevention focuses on controlling those risk factors.

• Control atrial fibrillation – Anticoagulation per CHA₂DS₂‑VASc score, rhythm management, and regular cardiology follow‑up.
• Manage hypercoagulable states – Genetic testing when indicated, lifelong anticoagulation for high‑risk disorders.
• Maintain cardiovascular health – Blood pressure < 130/80 mmHg, LDL‑C < 100 mg/dL, smoking cessation, weight management.
• Prevent deep‑vein thrombosis (DVT) – Early ambulation after surgery, compression stockings, prophylactic LMWH in high‑risk patients.
• Vaccinate – For patients with known functional asplenia or after splenectomy, and annually for influenza.
• Prompt treatment of infections – Especially in sickle‑cell disease or immunocompromised individuals.

Complications

If the infarct is extensive or left untreated, several serious complications may arise:

• Splenic abscess – Fever, worsening pain; may require percutaneous drainage or splenectomy.
• Splenic rupture – Sudden severe abdominal pain, hypotension; surgical emergency.
• Persistent or recurrent abdominal pain – Can affect quality of life.
• Secondary infection – Particularly in immunocompromised hosts.
• Sepsis and multi‑organ failure – Rare but life‑threatening.
• Overwhelming post‑splenectomy infection (OPSI) – In patients who eventually lose splenic function; rapid progression, high mortality.

When to Seek Emergency Care

Early recognition and treatment dramatically reduce the risk of serious complications and improve long‑term outcomes.

---

References

1. American College of Radiology. “Splenic Infarction: CT Findings.” Radiology, 2021.
2. Mayo Clinic. “Splenic Infarct.” Updated 2023. Link
3. National Heart, Lung, & Blood Institute. “Anticoagulation Therapy for Atrial Fibrillation.” 2022.
4. Cleveland Clinic. “Management of Asplenia and Splenectomy.” 2024.
5. World Health Organization. “Vaccines for Asplenic Persons.” 2022.
6. Jenkins, D. et al. “Outcomes of Conservative vs. Surgical Management of Splenic Infarction.” Annals of Hematology, 2020.

```